Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

AI takes on heart scans: can it match expert radiologists?

NCT ID NCT07340762

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing whether an artificial intelligence (AI) model can automatically write reports for cardiac MRI scans as accurately as experienced radiologists. Researchers will compare AI-generated reports with those written by experts using 20,000 patient scans. The goal is to see if the AI can correctly identify key findings, but the AI reports are not used for patient care in this study.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
large language model (AI software)
What this could lead to
If successful, this could lead to faster, more consistent cardiac MRI reporting, reducing radiologist workload.
What could go wrong
This is an observational study, not a treatment trial. The AI reports are not used for patient care, and the technology may not be accurate enough for real-world use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

20,000 people

The number who actually took part.

Started

Oct 2025

Expected to finish

Jan 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population consists of patients who underwent routine, clinically indicated cardiac magnetic resonance (CMR) examinations at a medical center,represents a real-world clinical population undergoing cardiac MRI for diagnostic evaluation of various cardiovascular diseases. All CMR studies included in this observational study are retrospectively collected, fully de-identified, and accompanied by corresponding radiologist-authored clinical reports. The study population represents a real-world clinical cohort with a range of cardiac conditions commonly evaluated by CMR.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients who underwent clinically indicated cardiac magnetic resonance (CMR) examinations. * Availability of complete and de-identified CMR image data. * Availability of corresponding clinical CMR reports authored by experienced cardiovascular radiologists. * CMR studies acquired using standard clinical imaging protocols. Exclusion Criteria: * Incomplete or corrupted CMR image data. * Absence of a reference radiologist report. * Poor image quality that precludes reliable clinical interpretation. * CMR studies with severe imaging artifacts affecting diagnostic evaluation.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HCM - hypertrophic cardiomyopathy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College

    Beijing, Beijing Municipality, 100037, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.